Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes
暂无分享,去创建一个
[1] G. Chimini,et al. Recognition of oligonucleotide-encoded T cell epitopes introduced into a gene unrelated to the original antigen , 1989, The Journal of experimental medicine.
[2] A. McMichael,et al. Class I cross-restricted T cells reveal low responder allele due to processing of viral antigen , 1989, Nature.
[3] S. Beck,et al. Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters , 1990, Nature.
[4] J. Cossins,et al. A 15 amino acid fragment of influenza nucleoprotein synthesized in the cytoplasm is presented to class I-restricted cytotoxic T lymphocytes , 1989, The Journal of experimental medicine.
[5] B. Coupar,et al. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen , 1988, The Journal of experimental medicine.
[6] Hidde L. Ploegh,et al. Peptide selection by MHC class I molecules , 1991, Nature.
[7] T. Braciale,et al. Recognition of pre-processed endogenous antigen by class I but not class II MHC-restricted T cells , 1989, Nature.
[8] Hans-Georg Rammensee,et al. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells , 1990, Nature.
[9] J. Yewdell,et al. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes. , 1989, Science.
[10] A. Townsend,et al. Antigen recognition by class I-restricted T lymphocytes. , 1989, Annual review of immunology.
[11] J. Monaco,et al. MHC class II region encoding proteins related to the muKidrug resistance family of transmembrane transporters , 1990, Nature.
[12] F Sherman,et al. The specificities of yeast methionine aminopeptidase and acetylation of amino-terminal methionine in vivo. Processing of altered iso-1-cytochromes c created by oligonucleotide transformation. , 1990, The Journal of biological chemistry.
[13] R. Demars,et al. A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway , 1990, Nature.
[14] Hans-Georg Rammensee,et al. Cellular peptide composition governed by major histocompatibility complex class I molecules , 1990, Nature.
[15] R. Webster,et al. DISQUISITIONS ON ORIGINAL ANTIGENIC SIN , 1966, The Journal of experimental medicine.
[16] B. Moss,et al. Murine cytotoxic T lymphocyte recognition of individual influenza virus proteins. High frequency of nonresponder MHC class I alleles , 1988, The Journal of experimental medicine.
[17] M. Bevan,et al. Class I-restricted presentation occurs without internalization or processing of exogenous antigenic peptides. , 1989, Journal of immunology.
[18] U. Koszinowski,et al. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein , 1991, Cell.
[19] H. Ljunggren,et al. Association of class I major histocompatibility heavy and light chains induced by viral peptides , 1989, Nature.
[20] J. Whitton,et al. Class I MHC can present an endogenous peptide to cytotoxic T lymphocytes , 1989, The Journal of experimental medicine.
[21] B. Moss,et al. Recognition of cloned influenza virus hemagglutinin gene products by cytotoxic T lymphocytes , 1986, Journal of virology.
[22] J. Bonifacino,et al. Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation , 1989, Nature.
[23] B. Coupar,et al. Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response , 1986, European journal of immunology.
[24] B. Moss,et al. Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques , 1985, Molecular and cellular biology.
[25] A. McMichael,et al. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides , 1986, Cell.
[26] M. Bevan,et al. Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization , 1989, The Journal of experimental medicine.
[27] B. Moss,et al. Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[28] S. Nathenson,et al. Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb molecule , 1990, Nature.
[29] J. Yewdell,et al. Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum. , 1990, Science.
[30] M. Kozak. The scanning model for translation: an update , 1989, The Journal of cell biology.
[31] T. Braciale,et al. Presentation of viral antigen to class I major histocompatibility complex-restricted cytotoxic T lymphocyte. Recognition of an immunodominant influenza hemagglutinin site by cytotoxic T lymphocyte is independent of the position of the site in the hemagglutinin translation product , 1991, The Journal of experimental medicine.
[32] J. Monaco,et al. Transport protein genes in the murine MHC: possible implications for antigen processing. , 1990, Science.
[33] S. Weissman,et al. Biology of simian virus 40 (SV40) transplantation antigen (TrAg). IX. Analysis of TrAg in mouse cells synthesizing truncated SV40 large T antigen. , 1983, Virology.
[34] R. Webster,et al. Disquisitions of Original Antigenic Sin. I. Evidence in man. , 1966, The Journal of experimental medicine.
[35] J. Rothbard,et al. Enhanced recognition of a modified peptide antigen by cytotoxic T cells specific for influenza nucleoprotein , 1988, Cell.